CELL FOUNDRY Trademark

Trademark Overview

On Monday, August 30, 2021, a trademark application was filed for CELL FOUNDRY with the United States Patent and Trademark Office. The USPTO has given the CELL FOUNDRY trademark a serial number of 97002906. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 21, 2024. This trademark is owned by Arsenal Biosciences, Inc.. The CELL FOUNDRY trademark is filed in the Pharmaceutical Products category with the following description:

Biologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
cell foundry

General Information

Serial Number97002906
Word MarkCELL FOUNDRY
Filing DateMonday, August 30, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements

Goods and ServicesBiologics for medical use, namely, biological preparations for the assessment of treatment options for, and the treatment and prophylaxis of, solid tumors and oncological diseases, disorders and conditions; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of solid tumors; biologics for medical use, namely, immune cell therapies and T-cell preparations for the treatment of oncological and infectious diseases, disorders and conditions; biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
NOT AVAILABLE"CELL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArsenal Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameArsenal Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, September 2, 2021NEW APPLICATION ENTERED
Thursday, October 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Thursday, November 4, 2021NON-FINAL ACTION WRITTEN
Thursday, November 4, 2021NON-FINAL ACTION E-MAILED
Thursday, November 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 17, 2021SUSPENSION LETTER WRITTEN
Friday, December 17, 2021LETTER OF SUSPENSION E-MAILED
Friday, December 17, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 8, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, July 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 24, 2023SOU EXTENSION 1 FILED
Monday, April 24, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 2 FILED
Tuesday, October 10, 2023SOU EXTENSION 2 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 20, 2024SOU EXTENSION 3 FILED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU EXTENSION 4 FILED
Monday, October 21, 2024SOU EXTENSION 4 GRANTED

Related Keywords

foundry cell biologics treatment namely medical diseases conditions disorders tumors oncological